Alpha Healthcare Acquisition Corp. III (ALPA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Alpha Healthcare Acquisition Corp. III (ALPA) with AI Score 49/100 (Weak). Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 18, 2026Alpha Healthcare Acquisition Corp. III (ALPA) Financial Services Profile
Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) targeting a merger within the U.S. healthcare sector. Incorporated in 2021, the company seeks to identify and acquire a promising healthcare business, offering investors exposure to potential growth through a business combination.
Investment Thesis
Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to successfully identify and merge with a promising healthcare company. The company's market capitalization stands at $0.19 billion, reflecting investor expectations regarding its acquisition prospects. A key value driver is the management team's expertise in sourcing and executing healthcare deals. However, the company's negative profit margin of -199.6% underscores its current lack of operational revenue. The investment thesis hinges on the successful completion of a merger within the next 12-24 months, which would serve as a major catalyst. Failure to do so could lead to liquidation and loss of investment. The gross margin of 59.3% is not relevant until a merger target is acquired.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.19 billion reflects investor sentiment regarding potential acquisition targets.
- Negative profit margin of -199.6% indicates the company's current lack of operating business and reliance on a future merger.
- Gross margin of 59.3% is not relevant until a merger target is acquired.
- The company operates as a SPAC, with its primary focus on identifying and merging with a healthcare business.
- No dividend yield, as the company is not generating revenue and is focused on completing an acquisition.
Competitors & Peers
Strengths
- Experienced management team with expertise in healthcare.
- Access to capital through public markets.
- Flexibility to pursue a wide range of healthcare businesses.
- Potential for high returns if a successful merger is completed.
Weaknesses
- Lack of operating history.
- Dependence on identifying and completing a successful merger.
- Competition from other SPACs.
- Risk of liquidation if a merger is not completed within the specified timeframe.
Catalysts
- Upcoming: Announcement of a definitive merger agreement with a target healthcare company.
- Upcoming: Completion of the merger transaction, providing access to a revenue-generating business.
- Ongoing: Positive developments in the healthcare industry, such as new technologies and treatments.
- Ongoing: Successful integration of the acquired company and realization of synergies.
Risks
- Potential: Failure to identify and complete a merger within the specified timeframe, leading to liquidation.
- Potential: Economic downturn impacting the healthcare industry and the value of potential merger targets.
- Potential: Changes in healthcare regulations negatively impacting the acquired company's business.
- Ongoing: Competition from other SPACs seeking to acquire healthcare companies.
- Ongoing: Integration challenges post-merger, hindering the realization of synergies.
Growth Opportunities
- Successful Merger Completion: The primary growth opportunity lies in successfully identifying and completing a merger with a high-growth potential healthcare company. The market size for healthcare acquisitions is substantial, with billions of dollars in deals occurring annually. A successful merger would provide Alpha Healthcare Acquisition Corp. III with a revenue-generating business and the potential for significant value creation for shareholders. The timeline for this opportunity is within the next 12-24 months, as SPACs typically have a limited timeframe to complete a merger.
- Operational Improvements Post-Merger: Once a merger is completed, there is an opportunity to improve the operational efficiency and profitability of the acquired company. This could involve streamlining operations, implementing new technologies, and expanding into new markets. The market size for operational improvements within the healthcare industry is significant, as many healthcare companies face challenges related to cost control and efficiency. The timeline for this opportunity is ongoing, as operational improvements can be implemented over several years.
- Strategic Acquisitions Post-Merger: After a successful initial merger, there is an opportunity to pursue strategic acquisitions to expand the company's market share and product offerings. The market size for healthcare acquisitions is substantial, with numerous companies seeking to grow through acquisitions. Strategic acquisitions could provide Alpha Healthcare Acquisition Corp. III with access to new technologies, markets, and customers. The timeline for this opportunity is medium-term, as it typically takes time to integrate an initial acquisition before pursuing additional deals.
- Expansion into New Geographies: There is an opportunity to expand the acquired company's operations into new geographic markets. The global healthcare market is vast and growing, with significant opportunities in emerging markets. Expanding into new geographies could provide Alpha Healthcare Acquisition Corp. III with access to new customers and revenue streams. The timeline for this opportunity is long-term, as it typically takes time to establish operations in new markets.
- Development of New Products and Services: There is an opportunity to develop new products and services to meet the evolving needs of the healthcare market. The healthcare industry is constantly innovating, with new technologies and treatments emerging regularly. Developing new products and services could provide Alpha Healthcare Acquisition Corp. III with a competitive advantage and the potential for significant revenue growth. The timeline for this opportunity is ongoing, as product development is a continuous process.
Opportunities
- Growing demand for healthcare services.
- Innovation in healthcare technology.
- Increasing number of private healthcare companies seeking to go public.
- Potential to create significant value through a successful merger.
Threats
- Economic downturn.
- Changes in healthcare regulations.
- Increased competition from other SPACs.
- Failure to identify and complete a successful merger.
Competitive Advantages
- Management team's expertise in sourcing and executing healthcare deals.
- Access to capital through the public markets.
- Ability to provide a private company with a faster and less regulated path to the public market.
About ALPA
Alpha Healthcare Acquisition Corp. III, incorporated in 2021 and based in New York, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and merge with a business in the healthcare industry within the United States. As a SPAC, Alpha Healthcare Acquisition Corp. III does not have significant ongoing operations of its own. Instead, it focuses on sourcing, acquiring, and managing a business through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company's strategy revolves around leveraging the expertise of its management team to identify a high-growth potential healthcare business and bring it to the public market. This approach allows investors to participate in the potential upside of the acquired company while mitigating some of the risks associated with early-stage investments. The success of Alpha Healthcare Acquisition Corp. III hinges on its ability to identify and execute a successful merger that creates value for its shareholders.
What They Do
- Identify potential merger targets in the healthcare industry.
- Conduct due diligence on potential merger targets.
- Negotiate merger agreements with target companies.
- Raise capital to fund the merger.
- Complete the merger transaction.
- Manage the acquired company post-merger.
Business Model
- Alpha Healthcare Acquisition Corp. III operates as a special purpose acquisition company (SPAC).
- The company raises capital through an initial public offering (IPO).
- The company uses the capital raised to acquire a private company in the healthcare industry.
- The acquired company becomes a publicly traded company through the merger with the SPAC.
Industry Context
Alpha Healthcare Acquisition Corp. III operates within the special purpose acquisition company (SPAC) segment of the financial services industry. SPACs have become a popular alternative to traditional IPOs, offering companies a faster and potentially less regulated path to the public market. The healthcare sector has been a particularly active area for SPAC mergers, driven by innovation, demographic trends, and increasing demand for healthcare services. The competitive landscape includes numerous SPACs seeking to acquire businesses in various sectors, including healthcare. The success of Alpha Healthcare Acquisition Corp. III depends on its ability to differentiate itself and secure a compelling merger target in a competitive market.
Key Customers
- Investors who participate in the IPO of Alpha Healthcare Acquisition Corp. III.
- The private company that is acquired by Alpha Healthcare Acquisition Corp. III.
- Shareholders of the merged company.
Financials
Chart & Info
Alpha Healthcare Acquisition Corp. III (ALPA) stock price: Price data unavailable
Latest News
No recent news available for ALPA.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALPA.
Price Targets
Wall Street price target analysis for ALPA.
MoonshotScore
What does this score mean?
The MoonshotScore rates ALPA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesCompetitors & Peers
Leadership: Rajiv Sarman Shukla
CEO
Rajiv Sarman Shukla is the CEO of Alpha Healthcare Acquisition Corp. III. His background includes extensive experience in the healthcare and financial sectors. He has held leadership positions in various healthcare companies, focusing on strategy, operations, and business development. Shukla's expertise spans across different segments of the healthcare industry, including pharmaceuticals, medical devices, and healthcare services. He has a proven track record of driving growth and creating value in healthcare organizations.
Track Record: Under Rajiv Sarman Shukla's leadership, Alpha Healthcare Acquisition Corp. III is actively pursuing a merger with a high-potential healthcare company. His strategic vision and industry knowledge are guiding the company's efforts to identify and evaluate potential targets. Shukla's experience in negotiating and structuring deals is crucial to the successful completion of a merger that will create value for shareholders. The company has not completed a merger as of 2026-03-18.
ALPA Financial Services Stock FAQ
What does Alpha Healthcare Acquisition Corp. III do?
Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare industry within the United States. The company does not have its own operating business but instead raises capital through an initial public offering (IPO) with the intention of acquiring an existing healthcare company. The goal is to take the acquired company public through the merger, providing investors with exposure to the healthcare sector. The success of ALPA depends on identifying and successfully merging with a promising healthcare business.
What do analysts say about ALPA stock?
As of 2026-03-18, there is no available analyst consensus on Alpha Healthcare Acquisition Corp. III (ALPA) stock. The company's valuation is primarily based on its potential to identify and merge with a successful healthcare company. Key considerations include the management team's expertise, the attractiveness of the target market, and the terms of the merger agreement. Investors should conduct their own due diligence and assess the risks and potential rewards associated with investing in a SPAC.
What are the main risks for ALPA?
The main risks for Alpha Healthcare Acquisition Corp. III include the failure to identify and complete a merger within the specified timeframe, which could lead to liquidation and loss of investment. There is also the risk that the acquired company may not perform as expected, leading to a decline in the value of the stock. Additionally, changes in healthcare regulations and increased competition from other SPACs could negatively impact the company's prospects. Investors should carefully consider these risks before investing in ALPA.
What are the key factors to evaluate for ALPA?
Alpha Healthcare Acquisition Corp. III (ALPA) currently holds an AI score of 49/100, indicating low score. Key strength: Experienced management team with expertise in healthcare.. Primary risk to monitor: Potential: Failure to identify and complete a merger within the specified timeframe, leading to liquidation.. This is not financial advice.
How frequently does ALPA data refresh on this page?
ALPA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ALPA's recent stock price performance?
Recent price movement in Alpha Healthcare Acquisition Corp. III (ALPA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Experienced management team with expertise in healthcare.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ALPA overvalued or undervalued right now?
Determining whether Alpha Healthcare Acquisition Corp. III (ALPA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ALPA?
Before investing in Alpha Healthcare Acquisition Corp. III (ALPA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on publicly available sources and may be subject to change.
- Investment in SPACs involves significant risks and may not be suitable for all investors.